A CASE OF DICLOFENAC-INDUCED AGRANULOCYTOSIS
- Authors: Dragomlretskaya N.1, Podzolkov V.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 24, No 2 (2013)
- Pages: 49-53
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115682
- ID: 115682
Cite item
Abstract
The wide use of drugs in different fields of medicine is followed by the higher incidence of adverse reactions, including agranulocytosis. The paper describes a case of agranulocytosis associated with diclofenac intake.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
N. Dragomlretskaya
I.M. Sechenov First Moscow State Medical University
Email: galanina_natalia@mail.ru
V. Podzolkov
I.M. Sechenov First Moscow State Medical University
Email: galanina_natalia@mail.ru
References
- Воробьев А.И. Руководство по гематологии. В 3 т. / М.: Ньюдиамед, 2002; 3: 112.
- Кассирский И.А, Алексеев Г.А. Клиническая гематология. 3-е изд. М.: ГИМЛ, 1962; с. 308-18.
- Козлова С.И., Демикова Н.С., Семанова Е.В. и др. Наследственные синдромы и медико-генетическое консультирование. Атлас-справочник / М.: Практика, 1996; 392 с.
- Насонова В.А., Бунчук Н.В. Руководство по внутренним болезням. Ревматические болезни / М.: Медицина. - 1997; с. 86-123.
- Bhatt V., Saleem A. Review: Drug-induced neutropenia - pathophysiology, clinical features, and management // Ann. Clin. Lab. Sci. - 2004; 34 (2): 131-7.
- Benichou C., Solal-Celigny P. Standartization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting // Nouv. Rev. Fr. Hematol. - 1993; 33: 257-62.
- Berliner N., Horwitz M., Loughran T. Congenital and acquired neutropenia. Hematology // Am. Soc. Hematol. Educ. Program. - 2004; 7: 63-79.
- Briers J. Agranulocytoses aigues medaicamenteuses // Rev. Prat. - 1999; 53: 73-7.
- Chamorey E., Magne N., Foa C. et al. Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes // Med. Sci. Monit. - 2004; 10 (11): 119-25.
- Distenfeld A., Seiter K., Talavera F. et al. Agranulocytosis // Am. J. Hematol. - 2003; 54 (6): 554-9.
- Ibanez L., Vidal X., Ballarin E. et al. Population-based drug-induced agranulocytosis // Arch. Intern. Med. - 2005; 165 (8): 869-74.
- Patton W., Duffull S. Idiosyncratic drug-induced haematological abnormalities // Drug. Safety. - 1994; 11 (6): 445-62.
- Peyro-Saint-Paul L., Roberge C., Auclair V. et al. Monitoring of iatrogenic neutropenia: importance of the pharmacovigilance analysis // Therapie. - 2004; 59 (6): 655-7.
- Sedky K., Shaaughnessy R., Hughes T. Clozapine-induced agranulocytosis after 11 years of treatment // Am. J. Psychiatry. - 2005; 162 (4): 814.
- Wong-Beringer A. Treating serious infections: focus on cefepime // Pharmacotherapy. - 2004; 24 (12, Pt. 2): 216-23.
Supplementary files
![](/img/style/loading.gif)